SciSparc Ltd. (SPRC) — SciSparc Ltd. announced: SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome.
Source: GlobeNewswire — read the full announcement there.
See our SciSparc company profile for background, links, and more SciSparc news.